Pediatric Brain Tumor Foundation

Pediatric Brain Tumor Foundation

Founded in 1991, the Pediatric Brain Tumor Foundation emerged from the efforts of families who lost children to brain tumors and recognized a critical gap in both research funding and support services. The foundation remains anchored by this dual mission: advancing scientific discovery while providing direct, practical help to affected families. It is not a grantmaking arm of a family office or a corporate foundation, but a standalone public charity built through community fundraising events and individual donations. The foundation's research strategy emphasizes translational science and clinician-scientist retention. It has funded work through the Pediatric Brain Tumor Consortium and the Pacific Pediatric Neuro-Oncology Consortium, among other collaborative networks. Grants typically target early-stage investigators and high-risk, high-reward projects that might not receive funding from larger government agencies. Direct family support programs include financial assistance for travel and lodging during treatment, educational resources, and a national peer-support network connecting parents and survivors. According to the foundation's public disclosures, it has invested more than $48 million in research and family support since its founding, funding over 100 research projects across leading pediatric oncology centers including St. Jude Children's Research Hospital, Dana-Farber Cancer Institute, and Children's Hospital of Philadelphia. The foundation operates national signature fundraising events, including the Ride for Kids motorcycle charity events and Starry Night 5K walks, which have engaged tens of thousands of participants across multiple states. The foundation's structural differentiator lies in its disease-specific mandate. Unlike larger cancer charities that spread resources across dozens of malignancies, the Pediatric Brain Tumor Foundation concentrates all its funding and advocacy on childhood brain tumors exclusively. This narrow focus allows it to cultivate deep expertise and fund research consortia that larger, more general funders might overlook. The foundation's board of directors includes parents of children with brain tumors, neuro-oncologists, and fundraising professionals, maintaining a governance structure directly tied to the patient community.